IBDEI3C1 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,2523,0)
;;=ACSC ASTHMA/BRONCHITIS/COPD^5^193
;;^UTILITY(U,$J,358.4,2524,0)
;;=ACSC CHF^6^193
;;^UTILITY(U,$J,358.4,2525,0)
;;=ACSC DEHYDRATION^7^193
;;^UTILITY(U,$J,358.4,2526,0)
;;=ACSC DIABETES TYPE 1^8^193
;;^UTILITY(U,$J,358.4,2527,0)
;;=ACSC DIABETES TYPE 2^9^193
;;^UTILITY(U,$J,358.4,2528,0)
;;=ACSC HYPERTENSION^10^193
;;^UTILITY(U,$J,358.4,2529,0)
;;=ACSC INFECTIOUS GASTROENTERITIS^11^193
;;^UTILITY(U,$J,358.4,2530,0)
;;=ACSC PNEUMONIA^12^193
;;^UTILITY(U,$J,358.4,2531,0)
;;=ACSC UTI^13^193
;;^UTILITY(U,$J,358.4,2532,0)
;;=ACSC VIRAL ENTERITIS^14^193
;;^UTILITY(U,$J,358.4,2533,0)
;;=E-CIG/VAPE LUNG INJURY^23^193
;;^UTILITY(U,$J,358.4,2534,0)
;;=ACSC ACUTE KIDNEY FAILURE^1^194
;;^UTILITY(U,$J,358.4,2535,0)
;;=ACSC ANGINA^2^194
;;^UTILITY(U,$J,358.4,2536,0)
;;=ACSC ASTHMA/BRONCHITIS/COPD^3^194
;;^UTILITY(U,$J,358.4,2537,0)
;;=ACSC CHF^4^194
;;^UTILITY(U,$J,358.4,2538,0)
;;=ACSC DEHYDRATION^5^194
;;^UTILITY(U,$J,358.4,2539,0)
;;=ACSC DIABETES TYPE 1^6^194
;;^UTILITY(U,$J,358.4,2540,0)
;;=ACSC DIABETES TYPE 2^7^194
;;^UTILITY(U,$J,358.4,2541,0)
;;=ACSC HYPERTENSION^8^194
;;^UTILITY(U,$J,358.4,2542,0)
;;=ACSC INFECTIOUS GASTROENTERITIS^9^194
;;^UTILITY(U,$J,358.4,2543,0)
;;=ACSC PNEUMONIA^10^194
;;^UTILITY(U,$J,358.4,2544,0)
;;=ACSC UTI^11^194
;;^UTILITY(U,$J,358.4,2545,0)
;;=ACSC VIRAL ENTERITIS^12^194
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3C1 1697 printed Nov 22, 2024@17:55:59 Page 2
IBDEI3C1 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,2523,0)
+2 ;;=ACSC ASTHMA/BRONCHITIS/COPD^5^193
+3 ;;^UTILITY(U,$J,358.4,2524,0)
+4 ;;=ACSC CHF^6^193
+5 ;;^UTILITY(U,$J,358.4,2525,0)
+6 ;;=ACSC DEHYDRATION^7^193
+7 ;;^UTILITY(U,$J,358.4,2526,0)
+8 ;;=ACSC DIABETES TYPE 1^8^193
+9 ;;^UTILITY(U,$J,358.4,2527,0)
+10 ;;=ACSC DIABETES TYPE 2^9^193
+11 ;;^UTILITY(U,$J,358.4,2528,0)
+12 ;;=ACSC HYPERTENSION^10^193
+13 ;;^UTILITY(U,$J,358.4,2529,0)
+14 ;;=ACSC INFECTIOUS GASTROENTERITIS^11^193
+15 ;;^UTILITY(U,$J,358.4,2530,0)
+16 ;;=ACSC PNEUMONIA^12^193
+17 ;;^UTILITY(U,$J,358.4,2531,0)
+18 ;;=ACSC UTI^13^193
+19 ;;^UTILITY(U,$J,358.4,2532,0)
+20 ;;=ACSC VIRAL ENTERITIS^14^193
+21 ;;^UTILITY(U,$J,358.4,2533,0)
+22 ;;=E-CIG/VAPE LUNG INJURY^23^193
+23 ;;^UTILITY(U,$J,358.4,2534,0)
+24 ;;=ACSC ACUTE KIDNEY FAILURE^1^194
+25 ;;^UTILITY(U,$J,358.4,2535,0)
+26 ;;=ACSC ANGINA^2^194
+27 ;;^UTILITY(U,$J,358.4,2536,0)
+28 ;;=ACSC ASTHMA/BRONCHITIS/COPD^3^194
+29 ;;^UTILITY(U,$J,358.4,2537,0)
+30 ;;=ACSC CHF^4^194
+31 ;;^UTILITY(U,$J,358.4,2538,0)
+32 ;;=ACSC DEHYDRATION^5^194
+33 ;;^UTILITY(U,$J,358.4,2539,0)
+34 ;;=ACSC DIABETES TYPE 1^6^194
+35 ;;^UTILITY(U,$J,358.4,2540,0)
+36 ;;=ACSC DIABETES TYPE 2^7^194
+37 ;;^UTILITY(U,$J,358.4,2541,0)
+38 ;;=ACSC HYPERTENSION^8^194
+39 ;;^UTILITY(U,$J,358.4,2542,0)
+40 ;;=ACSC INFECTIOUS GASTROENTERITIS^9^194
+41 ;;^UTILITY(U,$J,358.4,2543,0)
+42 ;;=ACSC PNEUMONIA^10^194
+43 ;;^UTILITY(U,$J,358.4,2544,0)
+44 ;;=ACSC UTI^11^194
+45 ;;^UTILITY(U,$J,358.4,2545,0)
+46 ;;=ACSC VIRAL ENTERITIS^12^194
